Abstract The activity of phospholipase
Introduction
Traditionally viewed as an organ of nutritional absorption, the gut also has complex defense mechanisms to prevent bacteria from entering the systemic circulation. The mucous layer is believed to protect the intestinal epithelium from potentially pathogenic bacteria. Alterations in the mucous layer may promote bacterial translocation (BT) under pathologic conditions such as gut immaturity, ischemia-reperfusion, starvation, bacterial stasis and overgrowth, and in¯ammatory bowel disease (IBD) [11] . We have previously reported that intestinal mucous phospholipid concentrations and content are altered in neonatal rabbits compared to adult rabbits [9] . We have also recently reported that lyso-phosphatidylcholine (L-PC), the hydrolysis product of phospatidylcholine (PC), the most prominent phospholipid in the mucous layer, promotes BT in an enterocyte-cell culture model. Phospholipase A 2 (PLA 2 ) comprises a family of lipolytic enzymes that catalyze the hydrolysis of the fatty acyl ester bond at the sn-2 position of glycero-3-phospholipids such as PC to produce free fatty acids and lysophospholipids such as L-PC. PLA 2 within the lumen of the intestine is derived from the pancreas and from mucosal Paneth-cell secretion (secretory PLA 2 ). Pancreatic PLA 2 functions in dietary and biliary phospholipid digestion whereas secretory PLA 2 functions within or on the exofacial surface of intestinal mucosal epithelia. It is clear that secretory PLA 2 plays an important role in a wide variety of in¯ammatory diseases, including septic shock, acute lung injury, in¯ammatory arthritides, and multisystem organ failure. Several human studies have documented that the activity of secretory PLA is elevated in the intestinal mucosa and serum of patients with both Crohn's disease and ulcerative colitis [6±8, 10] .
The pathophysiologic role of PLA 2 in intestinal inammation is not fully understood, however, most evidence suggests that the enzyme acts on cellular membrane phospholipids, generating pro-in¯ammatory molecules such as arachidonic acid and its metabolites (prostaglandins and leukotrienes) and lysophospholipids and their metabolites (platelet activating factor). Limited information is available regarding the possible role that luminal PLA 2 might play in intestinal disease by hydrolyzing extracellular or mucous phospholipids. The aim of this study utilizing an enterocyte monolayer model, was to examine whether PLA 2 can hydrolyze PC to the biologically active L-PC and then exert a biologic eect on parameters that accompany many intestinal in¯ammatory conditions such as intestinal epithelial permeability and BT.
Materials and methods
Materials included Caco-2 cells (American Type Culture Collection No. HTB 37, Manassas, VA), Escherichia coli C 25 (provided by Dr. Henri R. Ford, Pittsburgh, PA), Dulbecco's modi®ed Eagle's medium (DMEM), fetal bovine serum, non-essential amino acids solution, sodium pyruvate, penicillin G, streptomycin, and trypsin-EDTA (Gibco, Grand Island, NY), a two-chamber cellculture system (CCS), chloroform, methanol, CuSO 4 pentahydrate, concentrated H 3 PO 4 , and MacConkey's agar (Fischer, Pittsburgh, PA), rat tail type I collagen, dextran blue, PC, and L-PC (Sigma, St Louis, MO), PLA 2 (Naja naja cobra venom, Sigma), brain-heart infusion medium (BBL, Cockeysville, MD), and precoated silica gel plates (TLC plates, Silica gel 60, EM Science, Gibbstown, NJ).
Caco-2 cells are transformed human colon carcinoma cells that display many features of dierentiated small-intestinal enterocytes. They spontaneously form polarized monolayers with tight junctions, and the apical surface of the cells has well-developed microvilli that contain disaccharidases and peptidases typical of normal small-intestinal villous cells. The Caco-2 cell line has been used extensively to study enterocyte interactions with bacteria such as E. coli.
Cell passages 26±37 were grown in DMEM supplemented with 10% fetal bovine serum, 1% non-essential amino acids solution, 1% sodium pyruvate, penicillin G (100 IU/ml) and streptomycin (100 g/ml) in a 5% CO 2 atmosphere at 37°C. After reaching 60%± 70% con¯uence, cells were harvested by trypsinization with trypsin-EDTA, washed, and resuspended in DMEM, and then seeded at a density of 1´10 4 cells per well (0.33 cm 2 ) onto collagencoated porous ®lters in the apical chamber of a two-chamber CCS. Collagen coating of the plates was accomplished by incubation in 30 l 1.0 mg/ml rat-tail type I collagen. The cells were then grown for 14 days in DMEM to allow them to reach con¯uence and fully dierentiate. Media were changed every 2nd day.
PC and L-PC liposomes were prepared by dissolving each PL in chloroform:methanol (2:1), drying under a stream of dry nitrogen, resuspending in PBS, and subjecting them to sonication (Branson Soni®er 450; Danbury, CT).
Transepithelial electrical resistance (TEER), a measure of monolayer integrity and tight-junction permeability, was measured before and 2 h after adding the following: PLA 2 alone (0.2, 1.0, 5.0 IU/ml) in phosphate buered saline (PBS), PC alone (2 mM), L-PC alone (2 mM), or PLA 2 (0.2, 1.0, 2.5, 5.0 IU/ml) + PC (2 mM) using an epithelial voltohmmeter (EVOM; World Precision Instruments, Sarasota, FL) and expressed as the ratio of post-to pre-TEER. TEER values obtained in the absence of cells were considered as background, and resistances were calculated in W/cm 2 . Translocated bacteria were measured according to previously published methodology [5, 13] with minor modi®cations. Brie¯y, E. coli C 25, a nonpathogenic, streptomycin-resistant strain originally isolated from human gut¯ora, were grown overnight in brain-heart infusion medium, washed three times with PBS, and resuspended in PBS at a concentration of 1´10 7 colony forming units (CFU) per milliliter. The initial concentration of bacteria was determined spectrophotometrically at a wavelength of 650 nm.
Prior to addition of bacteria, the Caco-2 monolayers were washed three times with DMEM without fetal bovine serum or antibiotic supplements. PLA 2 alone, PC alone, L-PC alone, or PLA 2 + PC were added onto the Caco-2 cell monolayers. After 30 min stabilization, E. coli C 25 were inoculated by adding 100 ll DMEM containing 1´10 6 CFU bacteria into the apical media. Following an additional 120 min incubation at 37°C in 5% CO 2 , samples from the basal chambers were taken and the number of bacterial CFU was determined by the pour-plate assay using MacConkey's agar. The magnitude of BT was expressed as log 10 [CFU/ml].
Dextran Blue (DB) (2,000,000 molecular weight) was used to verify the integrity of Caco-2 cell monlayers. PBS (600 ll) was added to the basal chambers, followed by the addition of the PLA 2 and PL liposomes. A 50-ll aliquot of DB solution dissolved in PBS (20 mg/ml) was added to the apical chamber. Following 120 min of incubation, a 500-ll sample from the basal chamber was taken and DB permeability across the Caco-2 monolayer was quanti®ed by spectrophotometry (620 nm) and comparison made to a standard curve.
Thin-layer chromatography (TLC) was utilized to measure PLA 2 hydrolysis of PC to L-PC. Phospholipids were extracted using a modi®cation of the method described by Bligh and Dyer [2] . After 120 min of incubation of PL liposomes and/or PLA 2 in the apical chamber overlying the Caco-2 monolayer, 100-ll samples from the chamber were transferred to glass tubes with Te¯on screw caps; 3 ml chloroform:methanol (2:1) and 700 ll PBS were added and vortexed for 30 s. The upper layer of each tube was discarded and 1.0 ml methanol and 0.8 ml 0.9% NaCl were added and vortexed for an additional 30 s. After the upper layer of each tube was discarded by suction, the extracted lipid in the lower layer was evaporated to dryness under a stream of nitrogen and resuspended in 0.5 ml chloroform:methanol (2:1) and subjected to TLC; 10 ll of each sample was spotted on pre-coated silica gel plates. Spot separation was performed on 10´20-cm glass plates in solventsaturated chambers. The solvent system consisted of chloroformmethanol-7 N ammonia (60:35:5). After 40 min, the plates were dried, sprayed with 8% (w/v) CuSO 4 pentahydrate in water/ methanol/concentrated H 3 PO 4 (60:32:8), and charred for 15 min at 150°C. Each spot was recorded with a digital camera (DC 120 ZOOM, Kodak).
Statistical analysis was performed by one-way analysis of variance. Data were expressed as mean standard error of the mean, with statistical signi®cance de®ned as P < 0.05.
Results

Eect on transepithelial electrical resistance
As has previously been shown, the TEER ratio (post-TEER/pre-TEER) of Caco-2 monolayers pretreated with L-PC (2 mM) signi®cantly decreased compared to those treated with PC (2 mM) and PBS (Fig. 1) . However, PC (2 mM), the most prominent PL found in mucus, had no eect on TEER compared to PBS controls. At the lowest concentration tested (0.2 IU/ml), PLA 2 alone had a small but signi®cant eect to increase TEER compared to PBS. PLA 2 at higher concentrations (1.0 and 5.0 IU/ml) had no signi®cant eect on TEER compared to controls. When PC (2 mM) was added with PLA 2 at various concentrations, a signi®cant decrease in TEER was found at PLA 2 concentrations of 2.5 and 5.0 IU/ml.
Eect on BT
PC alone (2 mM) appeared to have a small inhibitory eect on BT across Caco-2 monolayers compared to PBS, however, this change did not reach statistical signi®cance (P 0.053) (Fig 2) . L-PC (2 mM), on the other hand, signi®cantly stimulated BT across Caco-2 monlayers compared to PC alone (2 mM) and PBS. Interestingly PLA 2 alone at the low concentration (0.2 IU/ml) signi®cantly inhibited BT compared to PBS controls. Higher concentrations of PLA 2 had no signi®-cant eect on BT compared to controls. When PC (2 mM) was added with PLA 2 across a range of concentrations, BT increased in a dose-dependent manner, reaching statistical signi®cance at 5.0 IU/ml PLA 2 . The magnitude of BT was similar between L-PC alone and PLA 2 (5.0 IU/ml) plus PC.
DB permeability
To test whether the eect of L-PC and PLA 2 + PC on TEER and BT were secondary to enterocyte monolayer disruption, permeability to the macromolecular marker DB was determined. In order to establish a basal rate of DB permeability from the apical to the basal chamber, permeability across the collagen-coated porous ®lters without cell monolayer was determined to be 18.7 7.0% (Table 1) . We found no DB permeability across control (PBS) Caco-2 monolayers or monolayers treated with PLA 2 PC, L-PC, or PLA 2 +PC.
Thin-layer chromatography
In order to con®rm our hypothesis that the addition of PC as substrate to the enzyme PLA 2 would result in L-PC production in our model, TLC was performed on incubated samples taken from the apical Caco-2 monolayer surface treated under the same conditions as the TEER and BT experiments. We found that, under our experimental conditions, L-PC was generated in a PLA 2 -dose-dependent manner (Fig. 3) . TLC performed on samples taken from the apical surface of monolayers treated with either PC alone or PLA 2 demonstrated no L-PC production.
Discussion
The mucous layer overlying the intestinal mucosa is a component of the gut epithelial barrier and is composed of a variety of molecules including phopholipids. Utilizing a human enterocyte cell-culture model, we have previously suggested that alterations in mucous phospholipid composition may result in altered epithelial permeability and BT [12] . The intestinal enzyme principally responsible for the metabolism of luminal dietary and biliary PLs is pancreatic PLA 2 ; however, little information is available about mucous PL metabolism at the apical, exofacial surface of the enterocyte. Secretory PLA 2 , predominantly released by Paneth cells within the small-intestinal mucosa under physiologic conditions, has been shown to markedly increase in conditions of intestinal in¯ammation. In addition, epithelial cells that do not typically secrete PLA 2 under normal conditions have been shown to develop signi®cant PLA 2 immunoreactivity in regions of mucosal in¯ammation in patients with Crohn's disease (CD) and ulcerative colitis [1, 8] . It is known that secretory PLA 2 hydrolyzes plasmamembrane PLs to biologically-active lyso-PLs and free fatty acids, which can function as in¯ammatory signaling molecules. However, to our knowledge, no previous studies have addressed the potential role of mucous PL metabolism on enterocyte permeability.
In this study we have described an in-vitro enterocyte cell-culture model that has allowed investigation of the eects of extracellular PC metabolism by PLA 2 on epithelial permeability. We found that the addition of both PLA 2 and PC to the enterocyte monolayer surface resulted in the extracellular production of L-PC. L-PC, added directly or generated by PC hydrolysis, was shown to dramatically decrease the TEER across the enterocyte monolayer. The decreased TEER, measured as a function of PC plus PLA 2 treatment, was not a result of PLA 2 action on plasma membrane PLs. In fact, at a low concentration of extracellular PLA 2 , TEER was slightly increased, perhaps as a result of some unestablished activity of the enzyme at the exofacial plasmamembrane surface. In addition, the eect of L-PC on TEER was not due to gross monolayer disruption as determined by the absence of DB permeability. This implies that the TEER eect of L-PC is at the level of the cellular tight junctions. BT across the gut epithelial barrier may be involved in a wide range of in¯ammatory conditions such as sepsis, shock, and IBD. BT has also been extensively studied in enterocyte cell-culture models. In this report, we have demonstrated that BT is increased when enterocyte monolayers are incubated with PLA 2 and PC. This eect is a direct result of L-PC production by PLA 2 hydrolysis of extracellular PC. The addition of PLA 2 alone to the enterocyte surface did not result in increased BT, as might be expected by a direct PLA 2 eect on enterocyte plasma-membrane PL metabolism. In fact, we found a decrease in BT when monolayers were incubated with PLA 2 alone. This inhibitory eect of PLA 2 on BT may be related to the reported ability of PLA 2 to act as an antimicrobial molecule by its capacity to hydrolyze bacterial membrane phospholipids [4] . As with alterations in TEER, L-PC stimulated BT is not a result of monolayer disruption as determined by the absence of DB permeability. The eects of L-PC on TEER and BT are probably through dierent mechanisms in that TEER measures permeability at cellular tight junctions, while BT across intestinal epithelial cells is believed to be principally via a transcellular route involving receptor binding, engulfment, and trans-cellular transport [3] .
These results suggest that in-vivo conditions in which L-PC and/or PLA 2 levels are increased within the gut lumen or at the mucosal epithelial surface may alter intestinal barrier function with increased epithelial permeability, including BT. Our model should be helpful in elucidating the cellular mechanism(s) by which L-PC, and perhaps other bioactive mucous, biliary, and dietary lipids might regulate intestinal epithelial permeability. Therapeutic strategies designed to alter dietary or mucous lipids and their metabolites may play a role in treating a variety of disorders with altered intestinal permeability such as IBD, enterocolitis, and necrotizing enterocolitis.
